{
    "clinical_study": {
        "@rank": "11529", 
        "acronym": "MUCOPHAGES", 
        "arm_group": {
            "arm_group_label": "Cystic fibrosis (CF) patients", 
            "arm_group_type": "Experimental", 
            "description": "Cystic fibrosis patients whom induced sputum is collected in order to evaluate the efficacy of a cocktail of 10 bacteriophages."
        }, 
        "brief_summary": {
            "textblock": "Pulmonary phage therapy to treat bacterial infections of the respiratory tract have been\n      investigated in animals. The aim of the present study is to evaluate the efficacy of\n      bacteriophages in infecting Pseudomonas aeruginosa (PA) strains present in sputum samples. A\n      cocktail of 10 bacteriophages will be applied on 60 sputum samples obtained from cystic\n      fibrosis (CF) patients during 6 hours.We will determine the bacteria and bacteriophages\n      strains in sputum samples collected. Then the sensitivity of individual colony will be\n      tested."
        }, 
        "brief_title": "Bacteriophage Effects on Pseudomonas Aeruginosa", 
        "completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "condition": "Cystic Fibrosis", 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Fibrosis", 
                "Pseudomonas Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Informed consent\n\n          -  Affiliated or benefit from a disease insurance regimen\n\n          -  Men and women\n\n          -  Aged from at least 6 years old\n\n          -  Confirmed Diagnosis of cystic fibrosis based on presence of 2 mutations of CFTR gene\n             and/or 2 positive tests of sweat chloride and/or 2 measures of pathologic difference\n             of nasal potential associated to cystic fibrosis clinical signs.\n\n          -  Patients able to produce sputum\n\n          -  Pseudomonas aeruginosa Chronic infected patients\n\n        Exclusion Criteria:\n\n          -  Simultaneous participation to another project on anti-infection, anti-inflammatory or\n             modificating agents\n\n          -  Subjet in exclusion period\n\n          -  Law protected patient\n\n          -  Realisation of sputum production is contra-indicated"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "59", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01818206", 
            "org_study_id": "UF 8750"
        }, 
        "intervention": {
            "arm_group_label": "Cystic fibrosis (CF) patients", 
            "description": "Collection of induced sputum on cystic fibrosis patients in order to evaluate the efficacy of a cocktail of 10 bacteriophages.", 
            "intervention_name": "Collection of induced sputum in order to evaluate the efficacy of a cocktail of 10 bacteriophages.", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cystic Fibrosis", 
            "Bacteriophages", 
            "Pseudomonas aeruginosa", 
            "Sputum"
        ], 
        "lastchanged_date": "September 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Montpellier", 
                    "country": "France", 
                    "state": "Languedoc Roussillon", 
                    "zip": "34295"
                }, 
                "name": "CHU de Montpellier - H\u00f4pital Arnaud de Villeneuve CRCM"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Bacteriophages Effects on Pseudomonas Aeruginosa Presents in Sputum of Cystic Fibrosis (CF) Patients", 
        "overall_official": {
            "affiliation": "CHU de Montpellier - H\u00f4pital Arnaud de Villeneuve", 
            "last_name": "Rapha\u00ebl RC CHIRON, RC", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Committee for the Protection of Personnes", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Pseudomonas aeruginosa (PA) strains counts after 6 hours in presence of bacteriophage", 
            "safety_issue": "No", 
            "time_frame": "after 6 hours in presence of bacteriophage"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01818206"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Pseudomonas aeruginosa (PA) strains counts after 24 hours in presence of bacteriophage", 
                "safety_issue": "No", 
                "time_frame": "after 24 hours in presence of bacteriophage"
            }, 
            {
                "measure": "Bacteriophage counts after 6 hours incubation within sputum samples", 
                "safety_issue": "No", 
                "time_frame": "after 6 hours incubation within sputum samples"
            }, 
            {
                "measure": "Sensitivity of individual Pseudomonas aeruginosa (PA) colonies to bacteriophages", 
                "safety_issue": "No", 
                "time_frame": "Sensitivity of individual PA colonies to bacteriophages"
            }
        ], 
        "source": "University Hospital, Montpellier", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Montpellier", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}